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salivary gland: Case report and cell adhesion
molecules immunocytochemical profileAthanasios K. Poulopoulos *, Dimitrios Andreades,
Apostolos Epivatianos, Dimitrios AntoniadesDepartment of Oral Medicine & Pathology, Dental School of Thessaloniki, Aristotle University
of Thessaloniki, 54640 Thessaloniki, GreeceReceived 11 March 2005; accepted 20 March 2005Summary Basal cell adenocarcinoma (BCAC) is a rare salivary gland tumour, espe-
cially in minor glands, and is considered to be the malignant counterpart of basal
cell adenoma. The clinical, histological and immunohistochemical features of a case
involving the upper labial mucosa are described. In conclusion any tumor that shows
the characteristics of basal adenoma, on initial examination but has limited encap-
sulation, even a small number of mitotic figures, or even a suggestion of infiltration,
and altered expression of cell adhesion molecules, should be carefully examined for
the possibility of BCAC.c 2005 Elsevier Ltd. All rights reserved.
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9Introduction
Basal cell adenocarcinoma (BCAC) is a rare salivary
gland tumour, which is considered to be the malig-
nant counterpart of basal cell adenoma. BCAC is
accounting for only the 2.9% of malignant salivary
neoplasms.1 It affects predominantly the major741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
oi:10.1016/j.ooe.2005.03.006
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in minor glands.
Diagnosis of BCAC depends on finding features
similar to adenoma but with an infiltrative growth
pattern and exlusion of adenoid cystic carcinoma,
sialoblastoma and basaloid carcinoma.2 BCAC is
considered a low-grade malignancy but the clinico-
pathologic behaviour of this tumour, is still
unclear.
A case of BCAC of a minor salivary gland in the
upper labial mucosa is reported and its cell adhe-
sion molecules immunocytochemical profile is
described.ved.
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A 61 year-old male presented with a complaint of
swelling involving the upper labial mucosa that
had enlarged slowly for 3 years. Intraoral examina-
tion revealed a 1.5 cm diameter, painless, lobu-
lated mass with well defined borders and normal
overlying mucosa (Fig. 1). No neck masses or palpa-
ble lymph nodes were noticed. The patient was
otherwise in good health. No clinical signs of malig-
nancy were present. The patient complained of
spontaneous pain caused by irritation from the
adjacent tooth. The clinical impression was that
this was a salivary gland neoplasm.
Following local excision, histological examina-
tion with H&E staining revealed an unencapsulated
salivary gland neoplasm consisting of basaloid cells
with basophilic cytoplasm and hyperchromatic nu-
clei, and cuboidal ductal cells. The neoplasm
showed solid and tubulo-trabecular growth pat-
terns, which were intermixed with areas of necro-
sis and haemorrhage. The histologic diagnosis was
BCAC (Fig. 2a).Figure 2 (a) Histological appearance of BCAC (H&E, orig
membrane expression for most of the neoplastic cells (o
expression mainly on the membrane of cuboidal, ductal cell
Figure 1 Clinical appearance of a broad based mass on
the upper labial mucosa which was diagnosed as the
BCAC.Neoplastic cell population was composed of two
cellular forms: basaloid cells positive stained for
S100, vimentin and partially for a cocktail of cyto-
keratins (CK5, 6, 8, 17) and cuboidal, ductal cells,
strongly expressed cytokeratins and only partially
S100 protein. Neoplastic cells were almost totally
negative for SMA.
Furthermore by immunohistochemical methods
was detected the expression of cell adhesion mole-
cules E-cadherin, desmoglein-2, CD-44s, ICAM-1
and b4-integrin. Almost all neoplastic cells were
membrane positive for b4-integrin (Fig. 2b), espe-
cially peripherally, E-cadherin was expressed
mainly on the membrane of cuboidal, ductal cell
(Fig. 2c), desmoglein-2 was detected in almost all
neoplastic cells, intracellularly and furthermore
on the membrane of luminal cells (Fig. 3a), CD44s
expressed in the majority of both basaloid and duc-
tal cell especially in the centre of solid areas (Fig.
3b) and finally ICAM-1 was positive in a small num-
ber of neoplastic cells (Fig. 3c).
The lesion was considered completely excised
histologically, the postoperative period was
uneventfull, and there was no evidence of recur-
rence after 3 years of follow up.Discussion
BCAC is uncommon in the minor salivary glands.
Ninety percent of cases reported are in the major
glands, usually the parotid,1 four cases reported
in the submandibular gland and one in the sublin-
gual gland.3 Very few cases4–10 have been reported
in minor salivary glands of the palate, buccal muco-
sa, and labial mucosa as in our case. The average
age of reported cases was in the sixth decade11
and lesions presented as asymptomatic swellings
of long duration with pain and sudden increase in
size reported in only a few cases in the majorinal magnification ·40), (b) b4 integrin positive cellular
riginal magnification ·40) and (c) E-cadherin positive
(original magnification ·40).
Figure 3 (a) Desmoglein-2 positive expression in most of the neoplastic cells, intracellularly and on the membrane of
luminal cells (original magnification ·40), (b) CD44s positive expression in the majority of both basaloid and ductal cell
especially in the centre of solid areas (original magnification ·40) and (c) ICAM-1 positive expression in a small number
of neoplastic cells (original magnification ·40).
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identical.4,7
The diagnosis of BCAC may be difficult because
clinical examination, computed tomography, ultra-
sonography and magnetic resonance imaging occa-
sionally do not exclude other benign and malignant
salivary gland tumours, and microscopic examina-
tion of biopsy specimens sometimes is unable to
distinguish it from basal cell adenoma. If a tumour
has a marked similarity to basal cell adenoma, fur-
ther examination is necessary to determine the
final diagnosis. Semi-serial sections of the excised
tumour should be examined to determine whether
the tumour is infiltrating into the surrounding nor-
mal tissues.6 Although no specific histologic para-
metres are known to be predictors of biologic
behaviour, the mean mitotic index is slightly higher
in recurrent and metastatic tumors. Furthermore it
has been reported that the examination of cell pro-
liferation, apoptosis, and expressions of p53, bcl-2
and epidermal growth factor receptor may be use-
ful in distinguishing malignant basal cell tumours
arising in the salivary glands from their benign
counterparts.12
Reciprocal mesenchymal-epithelial interactions
are important for the development of salivary
glands and for the maintenance of the structure
of the adults glands. Our findings indicate that cell
adhesion expression may be a characteristic consti-
tutive phenotypic feature of salivary epithelial and
myoepithelial cells, which is preserved in neoplas-
tic proliferation. Whereas a possible downregula-
tion of CD 44 expression, concomitant with loss
of other cell-cell and cell – matrix adhesion mole-
cules, such as integrins and E – cadherin, may be
involved in tumor dedifferentiation and may
promote stromal invasion, eventually contributing
to the development of a more aggressive
phenotype.13,14
BCAC is a low-grade malignancy and local recur-
rence has been previously reported.11 Metastasis israre with few lesions spreading to lymph nodes and
one to the lung. The solid type appears to have the
highest risk of metastasis.11,15 There was no evi-
dence of metastasis in our case. As primary treat-
ment especially for the major glands, it has been
proposed surgical excision with wide margin to en-
sure complete removal of the tumour. Regional
lymph node dissection is recommended only if
there is evidence of metastatic disease. In minor
glands it has been proposed wide excision with fol-
low-up radiotherapy on the basis of a higher likeli-
hood of neural and vascular invasion.6,15 Further
studies concerning the clinical behaviour of BCAC
of minor salivary glands after primary treatment
including radiation therapy is necessary. If BCAC
is radiosensitive, conservative surgery for BCAC in
minor salivary glands may be a viable option.
In conclusion any tumor that shows the charac-
teristics of basal adenoma, on initial examination
but has limited encapsulation, even a small number
of mitotic figures, or even a suggestion of infiltra-
tion, and altered expression of cell adhesion mole-
cules, should be carefully examined for the
possibility of BCAC.References
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